343 related articles for article (PubMed ID: 30380697)
1. Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma.
Plissonnier ML; Herzog K; Levrero M; Zeisel MB
Viruses; 2018 Oct; 10(11):. PubMed ID: 30380697
[TBL] [Abstract][Full Text] [Related]
2. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
3. Roles of long noncoding RNAs in hepatocellular carcinoma.
Shi L; Peng F; Tao Y; Fan X; Li N
Virus Res; 2016 Sep; 223():131-9. PubMed ID: 27374059
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
5. Systems biology analysis of hepatitis C virus infection reveals the role of copy number increases in regions of chromosome 1q in hepatocellular carcinoma metabolism.
Elsemman IE; Mardinoglu A; Shoaie S; Soliman TH; Nielsen J
Mol Biosyst; 2016 Apr; 12(5):1496-506. PubMed ID: 27040643
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers for virus-induced hepatocellular carcinoma (HCC).
Mathew S; Ali A; Abdel-Hafiz H; Fatima K; Suhail M; Archunan G; Begum N; Jahangir S; Ilyas M; Chaudhary AG; Al Qahtani M; Mohamad Bazarah S; Qadri I
Infect Genet Evol; 2014 Aug; 26():327-39. PubMed ID: 24956436
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets.
Zhang Q; Pu R; Du Y; Han Y; Su T; Wang H; Cao G
Cancer Lett; 2012 Aug; 321(1):1-12. PubMed ID: 22425745
[TBL] [Abstract][Full Text] [Related]
8. Current status of hepatitis C virus infection in Korea.
Suh DJ; Jeong SH
Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection.
Hino K; Nishina S; Sasaki K; Hara Y
Free Radic Biol Med; 2019 Mar; 133():193-199. PubMed ID: 30268888
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K
Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
[TBL] [Abstract][Full Text] [Related]
12. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
Heo MJ; Yun J; Kim SG
Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus-induced hepatocellular carcinoma.
Goossens N; Hoshida Y
Clin Mol Hepatol; 2015 Jun; 21(2):105-14. PubMed ID: 26157746
[TBL] [Abstract][Full Text] [Related]
14. Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma.
Cheng P; Cheng Y; Su MX; Li D; Zhao GZ; Gao H; Li Y; Zhu JY; Li H; Zhang T
Asian Pac J Cancer Prev; 2012; 13(8):3741-5. PubMed ID: 23098464
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA in HCV infection and liver cancer.
Kumar A
Biochim Biophys Acta; 2011; 1809(11-12):694-9. PubMed ID: 21821155
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma.
Desjardins LA
Clin J Oncol Nurs; 2002; 6(2):107-8. PubMed ID: 11889672
[TBL] [Abstract][Full Text] [Related]
18. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
[TBL] [Abstract][Full Text] [Related]
19. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M
Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267
[TBL] [Abstract][Full Text] [Related]
20. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
